7Z38 image
Entry Detail
PDB ID:
7Z38
EMDB ID:
Keywords:
Title:
Structure of the RAF1-HSP90-CDC37 complex (RHC-I)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2022-03-01
Release Date:
2022-09-14
Method Details:
Experimental Method:
Resolution:
3.16 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Heat shock protein HSP 90-beta
Chain IDs:A, B
Chain Length:732
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:RAF proto-oncogene serine/threonine-protein kinase
Chain IDs:C
Chain Length:659
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Hsp90 co-chaperone Cdc37
Chain IDs:D
Chain Length:394
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
SEP D SER modified residue
Primary Citation
Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation.
Mol.Cell 82 3438 3452.e8 (2022)
PMID: 36055235 DOI: 10.1016/j.molcel.2022.08.012

Abstact

RAF kinases are RAS-activated enzymes that initiate signaling through the MAPK cascade to control cellular proliferation, differentiation, and survival. Here, we describe the structure of the full-length RAF1 protein in complex with HSP90 and CDC37 obtained by cryoelectron microscopy. The reconstruction reveals a RAF1 kinase with an unfolded N-lobe separated from its C-lobe. The hydrophobic core of the N-lobe is trapped in the HSP90 dimer, while CDC37 wraps around the chaperone and interacts with the N- and C-lobes of the kinase. The structure indicates how CDC37 can discriminate between the different members of the RAF family. Our structural analysis also reveals that the folded RAF1 assembles with 14-3-3 dimers, suggesting that after folding RAF1 follows a similar activation as B-RAF. Finally, disruption of the interaction between CDC37 and the DFG segment of RAF1 unveils potential vulnerabilities in attempting the pharmacological degradation of RAF1 for therapeutic purposes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures